SCHEMBL26115222

SCHEMBL26115222

CC(C)C1CNN=C1c1ccc(Cl)cc1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.34
▸ HPGD P15428 2/20 0.34
▸ SLC6A4 P31645 2/20 0.33
▸ SLC6A2 P23975 1/20 0.33
▸ SLC6A3 Q01959 1/20 0.33
▸ SIGMAR1 Q99720 2/20 0.33
▸ MAOB P27338 1/20 0.33
▸ MEN1 O00255 2/20 0.32
▸ KMT2A Q03164 2/20 0.32
▸ DRD4 P21917 1/20 0.32
▸ KDM4E B2RXH2 1/20 0.32
▸ HTT P42858 1/20 0.32
▸ PGR P06401 3/20 0.32
▸ NPSR1 Q6W5P4 1/20 0.31
▸ HTR2A P28223 1/20 0.31
▸ HTR2C P28335 1/20 0.31
▸ HTR2B P41595 1/20 0.31
▸ LMNA P02545 1/20 0.31
▸ ALPG P10696 1/20 0.31
▸ ALOX12 P18054 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9859567 0.77 PDE3B (0.42) ALDH1A1HPGDMAOBKDM4EHTT
SCHEMBL10969360 0.77 DRD1 (0.36) ALDH1A1HPGDMEN1KMT2ANPSR1
SCHEMBL9392792 0.72 HTT (0.49) ALDH1A1HPGDSLC6A4SLC6A2SLC6A3
SCHEMBL8670130 0.71 PGR (0.38) ALDH1A1MEN1KMT2AKDM4EHTT
SCHEMBL8301694 0.69 PTGS1 (0.36) ALDH1A1HPGDSLC6A4SLC6A2SLC6A3
SCHEMBL761385 0.69 ALDH1A1 (0.52) ALDH1A1HPGDSLC6A3MEN1KMT2A
SCHEMBL9859798 0.68 SLC6A3 (0.41) ALDH1A1SLC6A4SLC6A2SLC6A3MEN1
SCHEMBL9320540 0.67 HTT (0.35) ALDH1A1HPGDMAOBKDM4EHTT
SCHEMBL4855252 0.66 BRD4 (0.33) ALDH1A1HPGDSLC6A4SLC6A2SLC6A3
SCHEMBL8672275 0.66 SLC6A2 (0.39) ALDH1A1HPGDSLC6A4SLC6A2SLC6A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250248973-A1 CANNABINOID RECEPTOR 1 ANTAGONISTS/INVERSE AGONISTS AND USES THEREOF CORBUS PHARMACEUTICALS, INC. 2025-08-07 — — US disclosed
EP-4504179-A1 CANNABINOID RECEPTOR 1 ANTAGONISTS/INVERSE AGONISTS AND USES THEREOF Corbus Pharmaceuticals, Inc. (US) 2025-02-12 — — EP disclosed
WO-2023196556-A1 CANNABINOID RECEPTOR 1 ANTAGONISTS/INVERSE AGONISTS AND USES THEREOF CORBUS PHARMACEUTICALS, INC. (US) 2023-10-12 — — WO disclosed
WO-2023196556-A1 CANNABINOID RECEPTOR 1 ANTAGONISTS/INVERSE AGONISTS AND USES THEREOF CORBUS PHARMACEUTICALS, INC. (US) 2023-10-12 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250248973-A1 CANNABINOID RECEPTOR 1 ANTAGONISTS/INVERSE AGONISTS AND USES THEREOF CNR1, CNR2, GPR119 ALDH1A1 2140/4885HPGD 991/4885SLC6A4 1134/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback